EUVIMEDEUVIMED entdecken
Crossref

Genetic Diagnosis and Individualized Intervention Through Next-generation Sequencing in Pre-symptomatic, Atypical, or Mildly Symptomatic Cases

Kaori Aibara, Yuri Kitamura, Reiko Arakawa, Eri Kondo, Shinichi Hosokawa, Saeko Yoshizawa, Atsuko Nishikawa, Ichizo Nishino, Mitsumasa Fukuda, Eiichi Ishii, Mariko Eguchi, Kayoko Saito

Tokyo Women's Medical University Journal · 2025-07 · 9 · 58-68

DOI: 10.24488/twmuj.2025005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tokyo Women's Medical University Journal, 2025-07. Verfasst von Kaori Aibara und 11 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Conventional diagnoses of neuromuscular disorders (NMD) are insufficient for patients with absent or atypical symptoms. However, genetic diagnosis provides individualized insights for treatment and management. This study aimed to establish definitive diagnoses using next-generation sequencing (NGS) and to implement clinical management. This study also examines important considerations in NGS analyses.

Methods

Targeted sequencing with the NMD panel was performed for 21 undiagnosed cases, followed by comprehensive NGS analysis using the clinical exome sequencing panel.

Results

A girl with fukutin (FKTN) pathogenic variants and a boy with a dystrophin (DMD) pathogenic variant were genetically diagnosed with dilated cardiomyopathy (DCM) and underwent strict management by pediatric cardiologists. The oldest reported case of a bcl-2-associated athanogene-3 (BAG3) pathogenic variant was diagnosed with myofibrillar myopathy 6. A man with mild symptoms was diagnosed with congenital myasthenic syndrome 7A due to a synaptotagmin 2 (SYT2) pathogenic variant, which showed potential for treatment. A patient with nemaline myopathy 2, caused by nebulin (NEB) pathogenic variants, is under respiratory monitoring.

Conclusions

In presymptomatic or atypical cases, a definitive diagnosis was achieved using clinical information, conventional testing, and NGS analysis, and specific clinical management strategies were developed. Individualized interventions, including revisiting conventional testing based on NGS findings, are useful.

Schlagwörter

next-generation sequencing (ngs)fukutin (fktn)dystrophin (dmd)bcl2-associated athanogene 3 (bag3)synaptotagmin 2 (syt2)

Zitieren

APA

Aibara, K., Kitamura, Y., Arakawa, R., Kondo, E., Hosokawa, S., Yoshizawa, S., Nishikawa, A., Nishino, I., Fukuda, M., Ishii, E., Eguchi, M., & Saito, K. (2025). Genetic Diagnosis and Individualized Intervention Through Next-generation Sequencing in Pre-symptomatic, Atypical, or Mildly Symptomatic Cases. Tokyo Women's Medical University Journal, 9(0), 58-68. https://doi.org/10.24488/twmuj.2025005

Vancouver

Aibara K, Kitamura Y, Arakawa R, Kondo E, Hosokawa S, Yoshizawa S, et al. Genetic Diagnosis and Individualized Intervention Through Next-generation Sequencing in Pre-symptomatic, Atypical, or Mildly Symptomatic Cases. Tokyo Women's Medical University Journal. 2025;9(0):58-68. doi:10.24488/twmuj.2025005

BibTeX
@article{Aibara2025,
  author = {Aibara, Kaori and Kitamura, Yuri and Arakawa, Reiko and Kondo, Eri and Hosokawa, Shinichi and Yoshizawa, Saeko and Nishikawa, Atsuko and Nishino, Ichizo and Fukuda, Mitsumasa and Ishii, Eiichi and Eguchi, Mariko and Saito, Kayoko},
  title = {Genetic Diagnosis and Individualized Intervention Through Next-generation Sequencing in Pre-symptomatic, Atypical, or Mildly Symptomatic Cases},
  journal = {Tokyo Women's Medical University Journal},
  year = {2025},
  volume = {9},
  number = {0},
  pages = {58--68},
  doi = {10.24488/twmuj.2025005}
}
Kostenlos starten →